Kah-lok Y. Chan

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Detecting T-cell clones of uncertain significance using anti-TRBC1-based flow cytometry.

Detecting T-cell clones of uncertain significance using anti-TRBC1-based flow cytometry.

Journal: Pathology
Published: September 22, 2025

Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8+ T-cell subsets.

Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8+ T-cell subsets.

Journal: Leukemia & lymphoma
Published: March 31, 2025

Endoscopic Ultrasound Guided Portal Pressure Gradient Measurement in Predicting Outcomes of Abdominal Surgery in Patients With Chronic Liver Disease.

Endoscopic Ultrasound Guided Portal Pressure Gradient Measurement in Predicting Outcomes of Abdominal Surgery in Patients With Chronic Liver Disease.

Journal: Journal of gastroenterology and hepatology
Published: March 07, 2025

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.

Journal: Blood advances
Published: November 05, 2018

HBO1 is required for the maintenance of leukaemia stem cells.

HBO1 is required for the maintenance of leukaemia stem cells.

Journal: Nature
Published: September 05, 2018

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

Journal: Leukemia & lymphoma
Published: October 13, 2017

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia.

Journal: Blood advances
Published: December 18, 2016

Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.

Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement.

Journal: Leukemia & lymphoma
Published: August 26, 2016

Update and new approaches in the treatment of Castleman disease.

Update and new approaches in the treatment of Castleman disease.

Journal: Journal of blood medicine
Published: August 19, 2016

Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.

Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.

Journal: Leukemia & lymphoma
Published: June 22, 2016

Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.

Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.

Journal: British journal of haematology
Published: May 20, 2016

Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma.

Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma.

Journal: Leukemia & lymphoma
Published: December 31, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026